Just to be clear here. Mymetics' contract to manufacture Imugene's Herr-vax vaccine no longer in effect since 2015 after Imugene decided to use a different formulation/approach for their vaccine. And one of the links you provided leads them to go the other route.
This is the patent of the formulation the're using now:PCT/AU2016/050275, ‘A vaccine composition and uses thereof’, claims the specific P467-CRM197 plus Montanide adjuvant vaccine formulation commencing a Phase Ib clinical trial in 2016.